Correlation Between Hard To and Fate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Hard To and Fate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hard To and Fate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hard to Treat and Fate Therapeutics, you can compare the effects of market volatilities on Hard To and Fate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hard To with a short position of Fate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hard To and Fate Therapeutics.
Diversification Opportunities for Hard To and Fate Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Hard and Fate is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Hard to Treat and Fate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fate Therapeutics and Hard To is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hard to Treat are associated (or correlated) with Fate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fate Therapeutics has no effect on the direction of Hard To i.e., Hard To and Fate Therapeutics go up and down completely randomly.
Pair Corralation between Hard To and Fate Therapeutics
If you would invest 0.00 in Hard to Treat on October 12, 2024 and sell it today you would earn a total of 0.00 from holding Hard to Treat or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 95.0% |
Values | Daily Returns |
Hard to Treat vs. Fate Therapeutics
Performance |
Timeline |
Hard to Treat |
Fate Therapeutics |
Hard To and Fate Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Hard To and Fate Therapeutics
The main advantage of trading using opposite Hard To and Fate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hard To position performs unexpectedly, Fate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fate Therapeutics will offset losses from the drop in Fate Therapeutics' long position.Hard To vs. American Scientf | Hard To vs. Ingen Technologies | Hard To vs. Lifeline Biotechnologies | Hard To vs. Bioelectronics Corp |
Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |